Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating safety, tolerability and efficacy of Trichostatin A for onychomycosis, with the study cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trichostatin A (trichostatin A)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Onychomycosis of Toenail | Phase 2 | Status: ACTIVE_NOT_RECRUITING